Earnings call: BioMarin reports solid Q1 growth, plans strategic updates By Investing.com

Published on 26 Apr 2024 on Investing.com

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced strong first-quarter financials and strategic...

Read the rest of the article

Start tracking your investments with Statfolio

Last week, you might have seen that BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released its first...

Simply Wall St. via Yahoo Finance 30 Apr 2024

Robust portfolio of rare-disease therapies with a focus on genetic discovery.Strategic positionin...

GuruFocus.com via Yahoo Finance 27 Apr 2024

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced strong first-quarter financials and strategi...

Investing.com 26 Apr 2024

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMar...

Insider Monkey via Yahoo Finance 26 Apr 2024

Shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) fell 3.51% after the company reported a...

Investing.com 24 Apr 2024

Investors are always looking for stocks that are poised to beat at earnings season and BioMarin P...

Zacks via Yahoo Finance 24 Apr 2024

Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) has reported transactions by CEO Jean-Jacques Bienaime...

Investing.com 16 Apr 2024

BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Chief Accounting Officer, Erin Burkhart, has sold a...

Investing.com 13 Apr 2024

Biomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing a...

GuruFocus.com via Yahoo Finance 13 Apr 2024

Insight into Parnassus Value Equity Fund (Trades, Portfolio)'s Q1 2024 Investment Decisions Warni...

GuruFocus.com via Yahoo Finance 11 Apr 2024